NewsWhore
01-07-2011, 10:10 PM
AstraZeneca PLC said the U.S. Food and Drug Administration will take three more months to review the British company's application for vandetanib, a drug it is developing as a treatment for a rar
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/41841037/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/41841037/)